Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Insulet

Here's What to Expect From Insulet's Next Earnings Report

Insulet is set to release its first-quarter results next month, and analysts expect a double-digit earnings growth.

Stocks To Watch: Insulet Sees RS Rating Rise To 91

Stocks To Watch: Insulet Sees RS Rating Rise To 91

A Relative Strength Rating upgrade for Insulet shows improving technical performance.

Investors Business Daily

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth

Netflix is among the stocks with most bullish analyst ratings. (Netflix)

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

This medical device stock is in a base and its relative strength line hit a 52-week high. Insulet's insulin pump is now available in Canada.

Investors Business Daily

Insulet Stock: Is PODD Outperforming the Healthcare Sector?

As Insulet has outperformed relative to the healthcare sector over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Insulet Stock Outlook: Is Wall Street Bullish or Bearish?

Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Earnings Preview: What to Expect From Insulet's Report

Insulet is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit decline.

inkl

Read news from The Economist, FT, and more,
with one subscription

Insulin Device Maker Has Analysts Turning Bullish

Insulin Device Maker Has Analysts Turning Bullish

Insulet stock is near a buy point after gapping up on earnings. The company increased its full year sales guidance.

Investors Business Daily

Is Insulet Stock Outperforming the Dow?

Is Insulet Stock Outperforming the Dow?

Insulet has outperformed the Dow recently, and analysts remain strongly optimistic about the stock’s prospects.

Dow Jones Futures Fall After Bulls Fight Back; Palantir, SpaceX In Talks

Dow Jones Futures Fall After Bulls Fight Back; Palantir, SpaceX In Talks

Stock market bulls fought back Friday, mitigating a bearish week. Palantir was among the winners. A government shutdown crisis is over. Here's what to do now.

Investors Business Daily

Dow Jones Futures: CPI Inflation Due As Palantir, Nvidia Bounce

Dow Jones Futures: CPI Inflation Due As Palantir, Nvidia Bounce

Google broke out Tuesday as Tesla races. But Palantir, AppLovin and most growth stocks fell. CPI inflation data is on tap.

Investors Business Daily

Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?

Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?

As Insulet outperformed relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

International Business Times

Stocks To Watch: Insulet Sees RS Rating Rise To 93

Stocks To Watch: Insulet Sees RS Rating Rise To 93

Insulet sees its Relative Strength Rating hit the elite 90-plus level.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Insulet Joins Elite List Of Stocks With 95-Plus Composite Rating

Insulet saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 97.

Investors Business Daily

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024."

Investors Business Daily

Here Is Why Analysts See More Growth After Meta's Impressive Gains

Meta stock is just above a buy zone from a buy point at 544.23 ahead of earnings on Wednesday. Analysts see profits rising in fiscal 2024 and 2025.

The Conversation

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

Get all your
news in one place.

100’s of premium titles.
One news app.

Is Insulet Stock Outperforming the Nasdaq?

Insulet has outperformed the Nasdaq Composite over the past year and analysts remain strongly bullish about the stock’s prospects.

Stocks Close in the Red, Nvidia Trades Lower After Earnings Report

The Nasdaq 100 fell to a 2-week low on Wednesday, dragging down the broader market. Nvidia stock drops after the AI company released its earnings report.

Stocks Close Lower, Nvidia Trades Lower After Earnings Report

The Nasdaq 100 fell to a 2-week low on Wednesday, dragging down the broader market. Nvidia stock drops after the AI company released its earnings report.

Stocks Close Lower Ahead of Nvidia Earnings

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.18%. Stocks settled lower Wednesday, with the Nasdaq 100 falling to a 2-week low. Weakness...

Broader Market Lower as Chip Stocks Tumble

The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.81%. Weakness in chip stocks is weighing on the overall market ahead of quarterly earnings...

Stocks Mixed Ahead of Nvidia’s Earnings

The S&P 500 Index ($SPX ) (SPY ) today is down -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. US stocks today are narrowly mixed. Some mixed corporate news today is weighing on...

Is Wall Street Bullish or Bearish on Insulet Stock?

Despite Insulet’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Organisations

US Federal Reserve

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Government Shutdown

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

264,671 stories

Aotearoa New Zealand

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play